Raghav Ramdev News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Goldman Sachs invests in Aragen Life Sciences (GVK Bio) May 20, 2021 The company has invested more than $3.6 billion in capital since 2006 Goldman Sachs has acquired a significant minority stake in Aragen Life Sciences (Aragen), formerly known as GVK Biosciences, by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. Promoted by GV Sanjay Reddy of the Hyderabad based GVK Group in 2001, it has become a specialised contract ...

Synopsis Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. The company serves a worldwide customer base which spans to the United States, Europe, and Japan. Wall Street behemoth Goldman Sachs has taken a significant minority stake in Aragen Life Sciences, formerly known as GVK Biosciences, a leading contract research organization (CRO), the company announced today. Goldman Sachs, an active investor in India, has acquired shares previously held by ChrysCapital and other existing shareholders. The priva...

Goldman Sachs Invests in Aragen Life Sciences Wednesday, May 19, 2021 11:55AM IST (6:25AM GMT)   Hyderabad, India:  Aragen Life Sciences (“Aragen”), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced today that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and manufacturing services ...